{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-039510","form_type":"8-K","ticker":"XBIT","cik":"0001626878","company_name":"XBiotech Inc.","filed_at":"2023-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.913379+00:00","generated_at":"2026-06-19T11:27:45.293402+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"XBiotech appoints Angela Hu as principal financial and accounting officer, replacing Queena Han","bullets":["Angela Hu, formerly Financial Controller, becomes principal financial and accounting officer effective February 10, 2023.","Queena Han's employment as VP Finance and HR ended February 3, 2023; she receives salary through February 15, 2023 for transition.","Hu's base salary increased to $200,000 per annum in connection with her promotion.","Hu has been with XBiotech since 2015, leading quarterly close, SEC filings, and external auditor coordination."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-039510","json":"https://secwatch.observer/filing/0001193125-23-039510.json","markdown":"https://secwatch.observer/filing/0001193125-23-039510.md","text":"https://secwatch.observer/filing/0001193125-23-039510.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626878/000119312523039510/0001193125-23-039510-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626878/000119312523039510/d459776d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T11:27:45.293402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c7e1907850","claim":"Queena Han departed as Vice President, Finance and Human Resource at XBiotech Inc..","evidence_excerpt":"Queena Han, whose employment as Vice President, Finance and Human Resource ended on February 3, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1626878/000119312523039510/0001193125-23-039510-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ended employment"},{"label":"Role","value":"Vice President, Finance and Human Resource"}],"fact_type":"executive_change"},{"claim_id":"d1ec218961","claim":"Angela Hu was appointed as Principal Financial Officer and Principal Accounting Officer at XBiotech Inc..","evidence_excerpt":"On February 10, 2023, Angela Hu, who presently serves as the Financial Controller of XBiotech Inc. (the “Company”), assumed the role as the Company’s principal financial officer and principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1626878/000119312523039510/0001193125-23-039510-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Financial Officer and Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}